Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an undisclosed amount to deploy Logica, an AI-powered drug solution, across several previously undrugged targets. This initiative aims to discover new medicines that address key unmet needs in a variety of disease areas, including cancer immunotherapy, autoimmunity, and […]
Immutep Limited, an Australian biotech company specializing in LAG-3 immunotherapies for cancer and autoimmune diseases, has partnered with Charles River Laboratories to conduct a GLP toxicology study for its preclinical candidate, IMP761, targeting autoimmune diseases. Developed as a first-in-class LAG-3 agonist antibody, IMP761 aims to address the root cause of autoimmune diseases by mitigating the […]
Duke Energy has commenced operations at the 250MW Pisgah Ridge Solar project in Navarro County, Texas, which is the American energy company’s largest solar power plant to date. The Pisgah Ridge solar power plant is owned and operated by Duke Energy Sustainable Solutions (DESS), which is the nonregulated commercial brand of the New York Stock […]
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories. The terms of the transaction were not disclosed. The new entity dubbed as AVS Bio will operate independently as a standalone platform for Arlington Capital Partners, and serve the biologic manufacturing and bioprocessing markets. AVS Bio offers […]
Duke Energy Sustainable Solutions, a commercial brand of Duke Energy, has broken ground on the 250MW Pisgah Ridge Solar project in Texas. Once operational, the Pisgah Ridge Solar project located in Navarro County will be the largest utility-scale solar facility in the portfolio of Duke Energy Sustainable Solutions. PPAs signed for the Pisgah Ridge Solar […]
Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based gene therapy contract development and manufacturing organization (CDMO) that offers viral vector-based gene delivery solutions. Vigene Biosciences also stands to earn up to $57.5 million in contingent additional payments based on its future performance. The acquisition is […]
Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to acquire HemaCare for about $380 million in an all-cash deal, as per the latest pharma acquisition news. HemaCare is engaged in the production of human-derived cellular products for the cell therapy market. The company provides critical biomaterials, […]
In a strategic move to bolster its position in the pharmaceutical research sector, Charles River Laboratories International, Inc. has agreed to acquire Michigan-based non-clinical contract research organization (CRO), MPI Research, for approximately $800 million. This acquisition is set to enhance Charles River’s capabilities in early-stage drug development and expand its service offerings across the biopharma […]